MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

The Role of Autophagy Lysosomal and Ubiquitin Proteasomal System in the Pathophysiology of Parkinson’s disease.

B. Adebisi (Akure, Nigeria)

Meeting: 2025 International Congress

Keywords: Alpha-synuclein, Cell death, Lysosomal disorders

Category: Parkinson's Disease: Pathophysiology / molecular mechanisms of disease

Objective: The research how to better understand the molecular mechanism initiating the etiology of Parkinson’s disease in order to appropriate the precise diagnosis and therapeutic approach to the neurodegenerative disease.

Background: Impairment of autophagy-lysosomal pathways (ALPs) is considered a significant pathogenic event in neurodegenerative disorders, including Parkinson’s disease (PD).

ALP modifications are seen in sporadic PD brains and in toxic and genetic rodent models of PD-associated neurodegeneration.

Moreover, PD-associated mutations and post-translational modifications of α-synuclein hinder its own lysosomal-mediated degradation, thus contributing to its buildup and aggregation.

Method: The research took into deep search of literatures articulated in the understanding of Parkinson’s disease, alpha synuclein biopathology and dysregulation of cellular protein metabolism.

Results: Impairment of autophagy-lysosomal pathways (ALPs) is  regarded as a major pathogenic event in neurodegenerative diseases, including Parkinson’s disease (PD). 

ALP alterations are observed in sporadic PD brains and in toxic and genetic rodent models of PD-related neurodegeneration. 

In addition, PD-linked mutations and post-translational modifications of α-synuclein impair its own lysosomal-mediated degradation, thereby contributing to its accumulation and aggregation. 

Furthermore, other PD-related genes, such as leucine-rich repeat kinase-2 (LRRK2), parkin, and phosphatase and tensin homolog (PTEN)-induced putative kinase 1 (PINK1), have been mechanistically linked to alterations in ALPs.

Conclusion: In Parkinson’s disease, the autosomal lysosomal system plays a critical role as its dysfunction, particularly in the degradation of alpha-synuclein protein, is considered a key pathogenic mechanism, with several genes linked to Parkinson’s directly impacting lysosomal function, leading to protein aggregation and neuronal damage; essentially, mutations in these genes disrupt the normal process of cellular waste disposal within the lysosome, contributing to the disease progression.

To cite this abstract in AMA style:

B. Adebisi. The Role of Autophagy Lysosomal and Ubiquitin Proteasomal System in the Pathophysiology of Parkinson’s disease. [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/the-role-of-autophagy-lysosomal-and-ubiquitin-proteasomal-system-in-the-pathophysiology-of-parkinsons-disease/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/the-role-of-autophagy-lysosomal-and-ubiquitin-proteasomal-system-in-the-pathophysiology-of-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley